Verified factor-similar pair

GSSC vs IJH

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB
Similarity score
80
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • GSSC has the higher backtested relative Sharpe (1.027 vs 1.011).
  • IJH has the lower published fee (0.05% vs 0.20%).
  • IJH is cheaper on dividend valuation (112 vs 126, where 100 is each fund's historical median).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

GSSC

TR Activebeta US Small Cap Equity ETF
SMB
Adj. R2
0.939
Rel. Sharpe
1.027
Mkt beta
0.89
AUM
US$921M
MER
0.20%
Valuation
126

IJH

iShares Core S&P Mid-Cap ETF
SMB
Adj. R2
0.942
Rel. Sharpe
1.011
Mkt beta
1.02
AUM
US$111.4B
MER
0.05%
Valuation
112

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
GSSC
+0.84
|t|
+14.5
IJH
+0.44
|t|
+15.5
diff +0.40
HML
GSSC
+0.09
|t|
+1.8
IJH
+0.12
|t|
+4.1
diff -0.03
RMW
GSSC
-0.05
|t|
-0.8
IJH
+0.14
|t|
+4.5
diff -0.20
CMA
GSSC
+0.09
|t|
+1.3
IJH
+0.03
|t|
+0.8
diff +0.06
UMD
GSSC
+0.09
|t|
+2.3
IJH
+0.01
|t|
+0.5
diff +0.08

Why This Pair Matches

Exposure level
76
Exposure shape
96
Mkt beta diff
0.13
Rel. Sharpe diff
0.017

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

GSSC fund page IJH fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.